These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21640561)

  • 1. Quantitative investigation, stability and in vitro release studies of anti-TB drugs in Triton niosomes.
    Mehta SK; Jindal N; Kaur G
    Colloids Surf B Biointerfaces; 2011 Oct; 87(1):173-9. PubMed ID: 21640561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of Tyloxapol niosomes for encapsulation, stabilization and dissolution of anti-tubercular drugs.
    Mehta SK; Jindal N
    Colloids Surf B Biointerfaces; 2013 Jan; 101():434-41. PubMed ID: 23010052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of a highly stable niosome and its hydrotrope-solubilization action to drugs.
    Liu T; Guo R
    Langmuir; 2005 Nov; 21(24):11034-9. PubMed ID: 16285768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of niosomes containing rifampicin for lung targeting.
    Jain CP; Vyas SP
    J Microencapsul; 1995; 12(4):401-7. PubMed ID: 8583314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Niosomal encapsulation of the antitubercular drug, pyrazinamide.
    El-Ridy MS; Abdelbary A; Nasr EA; Khalil RM; Mostafa DM; El-Batal AI; Abd El-Alim SH
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1110-8. PubMed ID: 21417612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome and niosome preparation using a membrane contactor for scale-up.
    Pham TT; Jaafar-Maalej C; Charcosset C; Fessi H
    Colloids Surf B Biointerfaces; 2012 Jun; 94():15-21. PubMed ID: 22326648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of proniosomes as an alternative strategy to optimize piroxicam transdermal delivery.
    Alsarra IA
    J Microencapsul; 2009 May; 26(3):272-8. PubMed ID: 18720197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged release biodegradable vesicular carriers for rifampicin--formulation and kinetics of release.
    Kamath MP; Shenoy BD; Tiwari SB; Karki R; Udupa N; Kotian M
    Indian J Exp Biol; 2000 Feb; 38(2):113-8. PubMed ID: 11218826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entrapment of multiple anti-Tb drugs in microemulsion system: quantitative analysis, stability, and in vitro release studies.
    Mehta SK; Kaur G; Bhasin KK
    J Pharm Sci; 2010 Apr; 99(4):1896-911. PubMed ID: 19894276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and characterization of ofloxacin niosomes.
    Ramalingam N; Natesan G; Dhandayuthapani B; Perumal P; Balasundaram J; Natesan S
    Pak J Pharm Sci; 2013 Nov; 26(6):1089-96. PubMed ID: 24191311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation on the stability of saquinavir loaded liposomes: implication on stealth, release characteristics and cytotoxicity.
    Ramana LN; Sharma S; Sethuraman S; Ranga U; Krishnan UM
    Int J Pharm; 2012 Jul; 431(1-2):120-9. PubMed ID: 22569226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
    Guinedi AS; Mortada ND; Mansour S; Hathout RM
    Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion of alpha-tocopherol in membrane models: probing the kinetics of vitamin E antioxidant action by fluorescence in real time.
    Gramlich G; Zhang J; Nau WM
    J Am Chem Soc; 2004 May; 126(17):5482-92. PubMed ID: 15113220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entrapment and release difference resulting from hydrogen bonding interactions in niosome.
    Hao YM; Li K
    Int J Pharm; 2011 Jan; 403(1-2):245-53. PubMed ID: 20971171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysaccharide coated niosomes for oral drug delivery: formulation and in vitro stability studies.
    Sihorkar V; Vyas SP
    Pharmazie; 2000 Feb; 55(2):107-13. PubMed ID: 10723768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of naftifine hydrochloride alcohol-free niosome gel.
    Barakat HS; Darwish IA; El-Khordagui LK; Khalafallah NM
    Drug Dev Ind Pharm; 2009 May; 35(5):631-7. PubMed ID: 18989805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adriamycin-loaded niosomes: drug entrapment, stability and release.
    Rogerson A; Cummings J; Florence AT
    J Microencapsul; 1987; 4(4):321-8. PubMed ID: 3504513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
    Wang H; Zhao P; Liang X; Gong X; Song T; Niu R; Chang J
    Biomaterials; 2010 May; 31(14):4129-38. PubMed ID: 20163853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol.
    Devaraj GN; Parakh SR; Devraj R; Apte SS; Rao BR; Rambhau D
    J Colloid Interface Sci; 2002 Jul; 251(2):360-5. PubMed ID: 16290741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of luciferase plasmid entrapped in cationic bilayer vesicles.
    Manosroi A; Thathang K; Werner RG; Schubert R; Manosroi J
    Int J Pharm; 2008 May; 356(1-2):291-9. PubMed ID: 18281170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.